Potential of CT-scan based tumor volume as a response indicator in chemotherapy of advanced epithelial ovarian cancer

Medical Science Monitor

Volumn 8, Issue 10, 2002, Pages

  Kumar, Pratik ^a   Rehani, Madan Mohan ^a   Kumar, Lalit ^a   Sharma, Raju ^a   Bhatla, Neerja ^a   Singh, Rajvir ^a   Sundaram, K Ramaiyer ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemotherapy; CT scan; Model; Ovarian cancer; Prediction; Tumor volume

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG RESISTANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PATIENT MONITORING; PROGNOSIS; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VOLUME; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; REGRESSION ANALYSIS; REMISSION; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; REMISSION INDUCTION; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0036774513     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Piver MS, Fanning J, Craig KA: Ovarian cancer, In: Knapp RC and Berkowitz RS, editors. Gynecologic Oncology. Singapore: Mc Graw-Hill International Editions, 1993
2. Esienkop SM, Spirtos NM, Montag TW et al: The impact of subspecialty training on the management of advanced ovarian cancer. Gynecol Oncol, 1992; 47: 203-209
3. Lambert HE, Soutter WP: Ovary and fallopian tube. In: Price P, Sikera K, Halnan KE, editors. Treatment of Cancer. London: Chapman & Hall Medical, 1995
4. Pratik Kumar, Rehani MM, Anand V et al: Assessment of lymph node tumour mass from CT scans: How good is diameter and visual assessment? J Med Phys, 1995; 20: 24
5. Allen DG, Baak J, Belpomme D et al: Advanced epithelial ovarian cancer: 1993 Consensus statements. Ann Oncol, 1993; 4(suppl 4): 83
6. Cohen MD, Wober T, Grosfeld J: Pre-operative evaluation of pediatric abdominal tumour volumes by computerised tomography. J Pediatr Surg, 1984; 19(3): 273
7. Aydin H, Richter E, Feyerabend T, Bohndorf W: In vivo determination of tumour volume: What does a CT-based calculation mean in recurrences of rectal carcinoma? Strahlenther Onkol, 1990; 166(3): 204
8. Barber HRK: Symptoms, signs and diagnosis. In: Ovarian Carcinoma: Etiology, Diagnosis and Treatment. New York: Springer-Verlag, 1993
9. Mortal CG, Hanley JA: The effect of measuring error on the results of therapeutic trial in advanced cancer. Cancer, 1976; 38: 388
10. Watson JW: What does response in cancer chemotherapy really mean? Br Med J, 1981; 38: 283
11. Spears CP: Volume doubling measurement of spherical and ellipsoidal tumours. Med Pediatr Oncol, 1984; 12: 212
12. Marrow CP: Malignant and borderline epithelial tumours of ovary: Clinical features, staging, diagnosis, intraoperative assessment and review of management. In: Malcom Coppleson, editor. Gynecologic Oncology, 1992
13. Morasca L, Balconi G, Erba E et al: Cytotoxic effect in vitro and tumour volume reduction in vivo induced by chemotherapeutic agents. Europ J Cancer, 1974; 10: 667
14. Skipper HE: Laboratory models: The historical perspective. Cancer Treat Rep, 1986; 70: 3
15. Gregory WM, Reznek RH, Hallett M, Slevin ML: Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volume. Br J Cancer, 1990; 62: 671
16. Cheung CWD, Johnson AE: Carcinoma of the breast: Measurements and the management of treatment. Br J Radiol, 1991; 64: 29
17. Cameron DA, Gregory WM, Bowman A, Leonard RCF: Mathematical modelling of tumour response in primary breast cancer. Br J Cancer, 1996; 73: 1409-1416
18. Frei III, Freireioh EJ, Gehan E et al: Studies of sequential and combination antimetabolite therapy in acute leukemia: 6-mer captopurine and methotrxate. Blood, 1961; 18: 431
19. Surbone A, Gilewski TA, Norton L: Cytokinetics. In: Holland JF, Bast RC, Morton DL et al. editors. Cancer Medicine. Williams and Wilkins, 1997
20. Norton L, Simon R: Growth curve of an experimental solid tumour following radiotherapy. J Nat Cancer Inst, 1977; 58: 1735
21. Norton L, Simon R: Tumour size, sensitivity to therapy and the design of treatment schedules. Cancer Treat Rep, 1977; 61: 1307
22. Buono RD, wright NA: The growth of human tumours. In: Peckham M, Pinedo HM and Veronesi U. editors. Oxford Text Book of Oncology. Oxford: Oxford Medical Publications 1995
23. Wiltshaw E: Ovarian cancer. In: Horwich A. editor. Oncology: A Multidisciplinary Text Book. Chapman & Hall, 1995
24. Ansell SM, Rapport BL, Falkson G et al: Survival determinants in patients with advanced ovarian cancer. Gynecol Oncol, 1993; 50: 215
25. Lawton FG, Kelly KA, Cassia LJS, Blackledge G: Speed and response to platinum-based chemotherapy: Implication for the management of epithelial ovarian cancer. Eur J Cancer Clin Oncol, 1987;23:1071
26. Goldie JH: Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy. Sem Oncol, 1987; 14: 1
27. Griffiths CT: Surgical resection of tumour bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Mongr, 1975; 42: 101